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Performance of commercially available component
resolved microarray has not been widely evaluated in
food allergy. Nut allergy is a prevalent and increasing
food allergy in which component resolved diagnosis is
crucial.
In the context of a multicentric study on pollen and
vegetable food allergy in Spain, we enrolled patients
(n=100) who had suffered at least two episodes of
immediate symptoms after ingestion of nuts (peanut,
walnut or hazelnut). Skin prick test was positive for the
corresponding nut. ImmunoCAP ISAC 112 was analyzed
in all patients and ImmunoCAP to the available compo-
nents from the studied sources were analyzed (Ara h 1,
Ara h 2, Ara h 3 and Ara h 8 and Ara h 9, Jug r 1, Jug r
3, Cor a 1, Cor a 8, Cor a 9, Cor a 14) in those patients
showing negative result to ISAC.
Among the 67 patients allergic to peanut 3 were sensi-
tized to Ara h 1, 3 to Ara h 2, 1 to Ara h 3, 9 to Ara h 6, 1
to Ara h 8 and 36 to Ara h 9. Twenty-seven peanut aller-
gic patients showed no sensitization to any components in
the microarray. Among these 27 ISAC negative peanut
allergic patients, 3 were sensitized to Ara h 1, 1 to Arah 2,
1 to Ara h 3, 1 to Ara h 8 and 23 to Ara h 9 by CAP.
Among the 69 patients allergic to walnut 7 were sensi-
tized to Jug r 1, 6 to Jug r 2 and 45 to Jug r 3. Eighteen
walnut allergic patient showed no sensitization to any
component in the microarray. Among these 18 ISAC
negative walnut allergic patients, 10 were sensitized to
Jug r 3 by CAP (none to Jug r 1).
Among the 56 patients allergic to hazelnut one was sen-
sitized to Cor a 1, 33 to Cor a 8 and 2 to Cor a 9. Twenty
hazelnut allergic patient showed no sensitization to any
components in the microarray. Among these 20 ISAC
negative hazelnut allergic patients, 10 were sensitized to
Cor a 8 by CAP (none to Cor a 1, Cor a 9 or Cor a 14).
Among the 100 patients allergic to peanut, walnut or
hazelnut, 40 patients did not show specific IgE against
the studied nuts/ components in ISAC.
Only a sixty per cent of the patients allergic to nuts
(peanut, walnut or hazelnut) are diagnosed by ISAC.
Sensitization to the lipid transfer proteins Ara h9, Jug r
3 and Cor a 8 was not detected by ISAC but it was
recovered by CAP analysis.
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